Kitidee, K., Amonyingcharoen, S., Preedagasamzin, S., Atjanasuppat, K., Sawaisorn, P., Srimorkun, P., . . . Hongeng, S. (2025). Combining CD3/GD2 bispecific T cell engager with human Vγ9Vδ2 T cells facilitates neuroblastoma cell targeting and killing in vitro. PLoS ONE, 20(6), 1. https://doi.org/10.1371/journal.pone.0325389
Chicago Style (17th ed.) CitationKitidee, Kuntida, et al. "Combining CD3/GD2 Bispecific T Cell Engager with Human Vγ9Vδ2 T Cells Facilitates Neuroblastoma Cell Targeting and Killing in Vitro." PLoS ONE 20, no. 6 (2025): 1. https://doi.org/10.1371/journal.pone.0325389.
MLA (9th ed.) CitationKitidee, Kuntida, et al. "Combining CD3/GD2 Bispecific T Cell Engager with Human Vγ9Vδ2 T Cells Facilitates Neuroblastoma Cell Targeting and Killing in Vitro." PLoS ONE, vol. 20, no. 6, 2025, p. 1, https://doi.org/10.1371/journal.pone.0325389.